Danimer Scientific, Inc. Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021	FY2020 12 months to Dec 31, 2020
Cash flows from operating activities
Net loss
Adjustments to reconcile net loss to net cash used in operating activities
Impairment of long-lived assets
Stock-based compensation
Depreciation and amortization
Amortization of debt issuance costs
Accounts receivable reserve
Bad debt provision
Inventory reserves
Loss on extinguishment of debt
Contract asset reserve
Gain on remeasurement of private warrants
Deferred income taxes
Gain on loan extinguishment
Loss on write-off of deferred loan costs
Amortization of right-of-use assets and lease liability
Gain on forgiveness of debt
(Gain) loss on disposal of fixed assets
Loss on disposal of assets
Other
Interest incurred but not paid
Changes in operating assets and liabilities, net of effects of aquisitions:
Accounts receivable
Other receivables
Inventories, net
Prepaid expenses and other current assets
Contract assets
Other assets
Accounts payable
Accrued liabilities
Other long-term liabilities
Unearned revenue and contract liabilities
Net cash used in operating activities
Cash flows from investing activities
Purchases of property, plant and equipment and intangible assets
Investment in leverage loans receivable related to NMTC financing
Acquisition of Novomer, net of cash acquired
Proceeds from sales of property, plant and equipment
Net cash used in investing activities
Cash flows from financing activities
Proceeds from long-term debt
Cash paid for debt issuance cost
Principal payments on long-term debt
Transaction costs related to Business Combination and PIPE offering
Proceeds from employee stock purchase plan
Proceeds from NMTC financing
Repurchase and retirement of common stock
Cash paid for debt issuance costs
Proceeds from issuance of common stock, net of issuance costs
Proceeds from exercise of stock options
Employee taxes related to stock-based compensation
Cost related to warrants
Proceeds from exercise of warrants, net of issuance costs
Proceeds from Business Combination and PIPE offering
Purchase of capped call options
Net cash provided by financing activities
Net increase (decrease) in cash and cash equivalents and restricted cash

Cash and cash equivalents and restricted cash
Cash and cash equivalents and restricted cash-beginning of period
Cash and cash equivalents and restricted cash-end of period
Cash paid for interest, net of interest capitalized
Cash paid for income taxes
Changes in accounts payable and accrued expenses for capital additions to property, plant and equipment
Extinguishment of NMTC leverage loan receivable
Extinguishment of NMTC debt
Conversion of convertible debt to common stock
Transaction costs in accounts payable and accrued expenses
Accounts payable settled directly by landlord
Net assets acquired from Live Oak in Business Combination

Comments